"I am not a cook". Richard Nixon and the baking ingredient that could help win the "war on cancer" In 1971 President Richard Nixon declared a “war on cancer” and signed the National Cancer Act into law. Forty years later we’re still waging that war, and cancer is still one of the leading causes of … Continue reading Using baking ingredient to create “nano” bombs and destroy cancer stem cells
CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell therapy has a lot of potential for Parkinson’s patients and the scientists that study it. One of our very own CIRM scholars, Maroof Adil, is making it his mission to develop stem cell based therapies to treat brain degenerating diseases like Parkinson’s. Maroof got his undergraduate degrees from MIT in both Chemical Engineering … Continue reading CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell stories that caught our eye: growing better bone, synthetic diaphragms, nerves that make music
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. A better way to grow bone. The term hydrogel gets tossed around a lot in tissue engineering discussions. The porous, generally pliable materials used to … Continue reading Stem cell stories that caught our eye: growing better bone, synthetic diaphragms, nerves that make music
UCLA scientists find new targets for late-stage prostate cancer
Prostate cancer, which currently affects 3 million men in the United States, is no longer a death sentence if caught early. The five-year survival rate is very high (~98%) because of effective treatments like hormone therapy, chemotherapy, surgery, and radiation—and for many men with slow progressing tumors, the wait-and-watch approach offers an alternative to treatment. … Continue reading UCLA scientists find new targets for late-stage prostate cancer
Smoking out Leukemia Cells to Prevent Cancer Relapse
Ninety-five percent of all patients with chronic myeloid leukemia (CML), carry a Frankenstein-like gene, called BCR-ABL, created from an abnormal fusion of two genes normally found on two separate chromosomes. Like a water faucet without a shutoff valve, the resulting mutant protein is stuck in an “on” position and leads to uncontrolled cell division and … Continue reading Smoking out Leukemia Cells to Prevent Cancer Relapse
Meet the proteins that tell stem cells where to move and how
Word cloud art work which shows all the proteins identified by the researchers The environment you grow up in can have a huge influence on how you turn out. That applies to people, and to stem cells too. Now a new study has identified 60 proteins that can have a big impact on how … Continue reading Meet the proteins that tell stem cells where to move and how
Type 1 Diabetes Trial Explained Whiteboard Video Style
There’s a saying, a picture is worth a thousand words. With complicated science however, pictures don’t always do these topics justice. Here’s where videos come to the rescue. Today’s topic is type 1 diabetes and a CIRM-funded clinical trial headed by the San Diego company ViaCyte hoping to develop a cure for patients with this disease. Instead of writing an entire … Continue reading Type 1 Diabetes Trial Explained Whiteboard Video Style
Giving Thanks by Looking Forward
The CIRM Team gather to give Thanks Thanksgiving is traditionally a time of reflection, a time to look back and express gratitude for all the good things that have happened in the past year. At CIRM we have a lot to be thankful for but this Thanksgiving we are looking forward, not backward. We’re unveiling … Continue reading Giving Thanks by Looking Forward
CIRM’s clinical trial portfolio: Two teams tackle blindness, macular degeneration and retinitis pigmentosa
More than seven million people in the US struggle to see. While most are not completely blind they have difficulty with, or simply can’t do, daily tasks most of us take for granted. CIRM has committed more than $100 million to 17 projects trying to solve this unmet medical need. Two of those projects have … Continue reading CIRM’s clinical trial portfolio: Two teams tackle blindness, macular degeneration and retinitis pigmentosa
Eyeing Stem Cell Therapies for Vision Loss
Back by popular demand (well, at least a handful of you demanded it!) we’re pleased to present the third installment of our Stem Cells in Your Face video series. Episodes one and two set out to explain – in a light-hearted, engaging and clear way – the latest progress in CIRM-funded stem cell research related … Continue reading Eyeing Stem Cell Therapies for Vision Loss
The Stem Cellar 